Patel Chem Specialities has notified BSE of an upcoming Board of Directors meeting scheduled for Friday, May 22, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation, dated May 14, 2026, was submitted by Managing Director Bhupesh Patel on behalf of the company.

Board Meeting Agenda

The board meeting has been convened to transact several key businesses. The following items are on the agenda for the meeting:

• Review, approve, and take on record the Annual Audited Financial Statement of the company along with the draft Auditor's Report for the year ended March 31, 2026
• Review, approve, and take on record the Audited Financial Results for the year ended March 31, 2026
• Consider and approve the Re-Appointment of M/s BIMAL SHAH ASSOCIATES, Chartered Accountants, as Internal Auditor for FY 2026-2027
• Consider and approve the Re-Appointment of M/s RTBR & Associates, Company Secretaries, as Secretarial Auditor for FY 2026-2027
• Consider and approve the appointment of M/s BRS & Associates, Cost Accountant, as Cost Auditor for FY 2026-27
• Any other matter with the permission of the Chairman

Key Meeting Details

The table below summarises the key details of the scheduled board meeting as submitted to the exchange:

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended by the SEBI (Prohibition of Insider Trading) Regulations, 2018, and the company's Code of Conduct for Regulating, Monitoring, and Reporting of Trading by Insiders, the trading window for dealing in the securities of Patel Chem Specialities has been closed since April 1, 2026. The trading window will reopen 48 hours after the declaration of the Audited Financial Results for the year ended March 31, 2026.

Patel chem specialities Limited has issued a clarification to BSE Limited regarding recent significant movements in its share price, stating that the fluctuations are purely market-driven and not related to any undisclosed corporate developments. The company's response, dated April 14, 2026, addressed BSE's inquiry from April 10, 2026, concerning the notable price movement in the company's equity shares.

Company's Official Response

In its communication to BSE, Patel Chem Specialities categorically stated that there is no undisclosed or price-sensitive information, nor any impending announcement or corporate development that could influence the share price or trading volume. The management emphasized that the company has no role in the recent movement of its share price.

Market-Driven Fluctuations

The company attributed the share price movements to external market conditions that are beyond its control or insight. According to the management, such fluctuations appear to be purely market-driven, suggesting that investor sentiment and broader market dynamics may be influencing the stock's performance rather than any company-specific factors.

Regulatory Compliance Assurance

Patel Chem Specialities reaffirmed its commitment to regulatory compliance, stating that it remains fully compliant with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided assurance that it will continue to disclose all material events, information, and actions that may impact investors or the market in a timely manner.

The clarification was signed by Bhupesh Patel, Managing Director, with DIN 02075545, and was digitally signed on April 14, 2026. This response demonstrates the company's proactive approach to addressing regulatory inquiries and maintaining transparency with stakeholders regarding share price movements.